|Tranylcypromine||Monoamine oxidase inhibitor|
|Trade names||Parstelin, Parmodalin, Jatrosom N, Stelapar|
Tranylcypromine/trifluoperazine (brand names Parstelin, Parmodalin, Jatrosom N, Stelapar) is a combination formulation of the monoamine oxidase inhibitor antidepressant drug tranylcypromine and the typical antipsychotic drug trifluoperazine that has been used in the treatment of major depressive disorder. It contains 10 mg tranylcypromine and 1 mg trifluoperazine. The drug has been in clinical use since at least 1961. It is still available in Italy with the name of Parmodalin.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|